What Are Neoplasms?

Neoplasms are abnormal masses of tissue arising from uncontrolled or dysregulated cell proliferation, in which affected cells no longer respond normally to the signals that govern growth, differentiation, and programmed death. The term is derived from the Greek for "new growth" and encompasses both cancerous and noncancerous masses throughout the body. Neoplasms are the subject of oncology, pathology, and an expanding body of biomedical engineering research focused on imaging, detection, and treatment technologies.

The distinction between a neoplasm and a normal repair response lies in the persistence and autonomy of growth: a neoplasm continues to enlarge even after the initiating stimulus is removed. This autonomous behavior results from accumulated genetic or epigenetic alterations that dysregulate cell cycle checkpoints, apoptotic pathways, or both. The American Cancer Society describes neoplasms as abnormal growths arising from malfunctions in normal cell replacement processes, a definition that covers the full spectrum from incidentally discovered benign masses to aggressive metastatic cancers.

Classification and Pathological Features

Neoplasms are classified along two principal axes: behavior (benign versus malignant) and histogenetic origin (the tissue type from which they arise). Benign neoplasms remain localized, typically grow slowly, and do not invade surrounding tissue or spread to distant sites. They may nonetheless cause clinical problems by compressing adjacent structures or secreting biologically active substances. Malignant neoplasms, collectively termed cancers, are distinguished by invasion of adjacent tissues and the potential for metastasis, in which cells break away from the primary tumor and establish secondary growths via the bloodstream or lymphatic system. Histopathological grading characterizes the degree of differentiation: well-differentiated (G1) tumors retain morphological resemblance to the parent tissue, while poorly differentiated (G3) tumors show marked deviation and generally carry a worse prognosis. Neoplasms are further categorized by origin as carcinomas (epithelial origin), sarcomas (mesenchymal or connective tissue origin), lymphomas and leukemias (hematopoietic origin), or gliomas and other tumors of neural tissue.

Diagnosis and Imaging

Definitive diagnosis of a neoplasm requires histopathological examination of tissue obtained by biopsy, which allows a pathologist to assess cellular morphology, mitotic activity, and architectural organization. Imaging modalities guide the initial detection and localization of suspected neoplasms. X-ray and computed tomography (CT) provide structural detail for solid masses; magnetic resonance imaging (MRI) offers superior soft-tissue contrast for brain, liver, and musculoskeletal tumors; and positron emission tomography (PET) uses radiolabeled glucose analogs to highlight metabolically active tissue, exploiting the elevated glucose uptake characteristic of many malignant neoplasms. Clinical consensus guidelines from bodies such as the American College of Radiology Appropriateness Criteria specify which imaging sequences and modalities are appropriate for particular suspected tumor types. Liquid biopsy techniques, which detect circulating tumor DNA or cells in peripheral blood, are an area of active development for earlier detection and monitoring of treatment response.

Treatment Modalities

Treatment of neoplasms depends on type, grade, stage, and the patient's overall condition. Surgical resection remains the primary curative option for localized solid tumors when anatomically feasible. Radiation therapy delivers ionizing radiation to tumor volumes using linear accelerators, with intensity-modulated and stereotactic techniques enabling dose shaping that spares adjacent normal tissue. Systemic therapies include cytotoxic chemotherapy, targeted molecular agents directed at specific oncogenic proteins, and immunotherapy approaches that restore or amplify immune recognition of tumor cells. Research on biomedical devices and signal processing methods for tumor detection and treatment monitoring is extensively documented in IEEE Xplore publications on cancer diagnosis and medical imaging.

Applications

Neoplasms research and treatment have applications in a wide range of fields, including:

• Medical imaging system design for tumor detection and staging
• Radiation therapy planning and delivery technology
• Biosensor development for liquid biopsy and circulating tumor DNA
• Machine learning algorithms for pathology slide analysis
• Drug delivery systems targeting tumor microenvironments
• Robotic surgery platforms for precision tumor resection